Government nearly exhausts monoclonal COVID treatment funding with new purchase
(WASHINGTON) -- Eli Lilly has announced the U.S. government is buying an additional 150,000 courses of the only monoclonal antibody therapy left that still holds up against all COVID-19 variants of concern, including BA.2.The new purchase of the therapy, called bebtelovimab, is costing the government... Read More.
